McKinsey Nears $500 Million Settlement in DOJ Opioid Probe

The consulting firm is close to resolving federal investigations into its role in boosting opioid sales.

McKinsey & Co. is in advanced talks to pay over $500 million to settle U.S. Justice Department investigations.
The settlement would address both criminal and civil probes into McKinsey's work with opioid manufacturers.
Federal scrutiny focuses on McKinsey's advice to companies like Purdue Pharma, linked to the opioid crisis.
Previously, McKinsey settled nearly $1 billion in lawsuits related to its opioid consulting practices.
The firm ceased advising on opioid-related businesses in 2019 and denies any admissions of wrongdoing in settlements.